New hope: immunotherapy combo trial could transform treatment for certain colon cancers
NCT ID NCT07403877
Summary
This study compares three different immunotherapy approaches given before surgery for people with locally advanced colorectal cancer that has specific genetic features (MSI-H/dMMR). Researchers want to see if combining two immunotherapy drugs, or adding radiation to immunotherapy, works better than single-drug immunotherapy alone. The goal is to shrink tumors before surgery and potentially help some patients avoid surgery altogether if their tumors disappear completely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (MSI-H) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.